RPGLIFE

Rpg Life Sciences Share PriceRPG Life Sciences

₹1,365.95
-13.8 (-1%)
As on 12 December, 2023 | 01:13 BSE: 532983 NSE: RPGLIFEISIN: INE105J01010

Rpg Life Sciences Performance

Day Range

  • Low 1,362.00
  • High 1,388.75
₹ 1,365.95

52 Week Range

  • Low 645.50
  • High 1,505.00
₹ 1,365.95
  • Open Price1,388.75
  • Previous Close1,379.75
  • Volume6126

Start SIP in RPG Life Sciences

Start SIP

Rpg Life Sciences Share Price

  • Over 1 Month -6.34%
  • Over 3 Month 8.67%
  • Over 6 Month 48.81%
  • Over 1 Year 53.78%

Rpg Life Sciences Key Statistics

P/E Ratio 29.2
PEG Ratio 1
Market Cap Cr 2,259
Price to Book Ratio 7.3
EPS 41.2
Dividend 0.9
Relative Strength Index 43.94
Money Flow Index 32.56
MACD Signal -0.14
Average True Range 46.55

Rpg Life Sciences Investment Rating

  • Master Rating:
  • R P G Life Sciences has an operating revenue of Rs. 550.45 Cr. on a trailing 12-month basis. An annual revenue growth of 17% is outstanding, Pre-tax margin of 18% is great, ROE of 21% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 32% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 8% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 95 which is a GREAT score indicating consistency in earnings, a RS Rating of 72 which is FAIR indicating the recent price performance, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 75 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

RPG Life Sciences Financials
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 154148118131135129104
Operating Expenses Qtr Cr 11611610310110510190
Operating Profit Qtr Cr 37321629302814
Depreciation Qtr Cr 4444444
Interest Qtr Cr 0000000
Tax Qtr Cr 9837773
Net Profit Qtr Cr 2622101920188
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 518443
Operating Expenses Annual Cr 410354
Operating Profit Annual in Cr 10386
Depreciation Cr 1616
Interest Annual Cr 01
Tax Annual Cr 2422
Net Profit Annual Cr 6851
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 9165
Cash from Investing Activity Annual Cr -106-35
Cash from Financing Annual Activity Cr -17-14
Net Cash Flow Annual Cr -3217
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 308256
Fixed Assets Annual Cr 150135
Total Non Current Assets Annual Cr 155138
Total Current Assets Annual Cr 264207
Total Assets Annual Cr 419345
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 186155
ROE Annual % 2220
ROCE Annual % 2928
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 2120
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr
Operating Expenses Qtr Cr
Operating Profit Qtr Cr
Depreciation Qtr Cr
Interest Qtr Cr
Tax Qtr Cr
Net Profit Qtr Cr
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr
Operating Expenses Annual Cr
Operating Profit Annual in Cr
Depreciation Cr
Interest Annual Cr
Tax Annual Cr
Net Profit Annual Cr
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr
Fixed Assets Annual Cr
Total Non Current Assets Annual Cr
Total Current Assets Annual Cr
Total Assets Annual Cr
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual --
EBDIT Annual Margin %

Rpg Life Sciences Technicals

EMA & SMA

Current Price
₹1,365.95
-13.8 (-1%)
pointer
  • Bullish Moving Average
  • ___
  • 5
  • Bearish Moving Average
  • ___
  • 11
  • 20 Day
  • ₹1,396.37
  • 50 Day
  • ₹1,368.75
  • 100 Day
  • ₹1,274.18
  • 200 Day
  • ₹1,126.05
  • 20 Day
  • ₹1,412.02
  • 50 Day
  • ₹1,384.72
  • 100 Day
  • ₹1,278.29
  • 200 Day
  • ₹1,047.04

Rpg Life Sciences Resistance and Support

PIVOT
₹1,372.24
Resistance
First Resistance 1,382.47
Second Resistance 1,398.98
Third Resistance 1,409.22
RSI 43.94
MFI 32.56
MACD Single Line -0.14
MACD -8.81
Support
First Resistance 1,355.72
Second Resistance 1,345.48
Third Resistance 1,328.97

Rpg Life Sciences Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 7,286 441,532 60.6
Week 17,046 913,815 53.61
1 Month 21,705 1,004,069 46.26
6 Month 48,330 2,078,173 43

Rpg Life Sciences Result Highlights

RPG Life Sciences Synopsis

NSE-Medical-Diversified

Rpg Life Sciences is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 512.81 Cr. and Equity Capital is Rs. 13.23 Cr. for the Year ended 31/03/2023. RPG Life Sciences Ltd. is a Public Limited Listed company incorporated on 29/03/2007 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24232MH2007PLC169354 and registration number is 169354.
Market Cap 2,261
Sales 550
Shares in Float 0.45
No of funds 32
Yield 0.87
Book Value 7.42
U/D Vol ratio 1.7
LTDebt / Equity
Alpha 0.17
Beta 0.8

RPG Life Sciences

Owner NameSep-23Jun-23Mar-23Dec-22
Promoters 72.81%72.81%72.81%72.61%
Mutual Funds 0.82%
Insurance Companies 0.51%
Foreign Portfolio Investors 0.46%0.33%0.38%0.25%
Financial Institutions/ Banks 0.01%0.01%0.01%
Individual Investors 18.41%19.45%19.91%20.26%
Others 6.98%7.4%6.9%6.87%

RPG Life Sciences Management

Name Designation
Mr. Harsh V Goenka Chairman
Mr. Yugal Sikri Managing Director
Mr. Rajat Bhargava Non Executive Director
Mr. Sachin Nandgaonkar Non Executive Director
Mr. Manoj K Maheshwari Independent Director
Mr. Narendra Ambwani Independent Director
Ms. Zahabiya Khorakiwala Independent Director
Mr. Bhaskar Iyer Independent Director
Dr. Lalit S Kanodia Independent Director
Mr. Mahesh S Gupta Independent Director

Rpg Life Sciences Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Rpg Life Sciences Corporate Action

Date Purpose Remarks
2023-10-18 Quarterly Results
2023-07-28 Quarterly Results
2023-04-28 Audited Results & Final Dividend
2023-02-01 Quarterly Results
2022-10-17 Quarterly Results
Date Purpose Remarks
2023-07-21 FINAL Rs.12.00 per share(150%)Final Dividend
2022-07-15 FINAL Rs.9.60 per share(120%)Final Dividend
2021-08-17 FINAL Rs.7.20 per share(90%)Dividend

RPG Life Sciences MF Shareholding

Name Amount(cr)
Mirae Asset Multicap Fund Regular Growth 1,731
Motilal Oswal S&P BSE Healthcare ETF 8

RPG Life Sciences FAQs

What is Share Price of RPG Life Sciences ?

RPG Life Sciences share price is ₹1,365 As on 12 December, 2023 | 00:59

What is the Market Cap of RPG Life Sciences ?

The Market Cap of RPG Life Sciences is ₹2259.1 Cr As on 12 December, 2023 | 00:59

What is the P/E ratio of RPG Life Sciences ?

The P/E ratio of RPG Life Sciences is 29.2 As on 12 December, 2023 | 00:59

What is the PB ratio of RPG Life Sciences ?

The PB ratio of RPG Life Sciences is 7.3 As on 12 December, 2023 | 00:59

Q2FY23